These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11502047)

  • 21. The role of beta-blockers in dilated cardiomyopathy.
    Waagstein F
    Curr Opin Cardiol; 1995 May; 10(3):322-31. PubMed ID: 7612984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M; Nodari S; Parrinello G; Giubbini R; Manca C; Dei Cas L
    Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage between mechanical and electrical alternans in patients with chronic heart failure.
    Kodama M; Kato K; Hirono S; Okura Y; Hanawa H; Yoshida T; Hayashi M; Tachikawa H; Kashimura T; Watanabe K; Aizawa Y
    J Cardiovasc Electrophysiol; 2004 Mar; 15(3):295-9. PubMed ID: 15030419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. A study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol.
    Andersson B; Lomsky M; Waagstein F
    Eur Heart J; 1993 Oct; 14(10):1375-85. PubMed ID: 8262085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline Blood Pressure and Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy with Spontaneous Mechanical Alternans.
    Watanabe M; Kashimura T; Ishizuka M; Kase M; Sakai R; Fujiki S; Takayama T; Ishihara S; Ozaki K; Inomata T
    Intern Med; 2023 Jun; 62(12):1707-1713. PubMed ID: 36351583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.
    Eichhorn EJ; Bedotto JB; Malloy CR; Hatfield BA; Deitchman D; Brown M; Willard JE; Grayburn PA
    Circulation; 1990 Aug; 82(2):473-83. PubMed ID: 1973638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
    Hara Y; Inoue K; Ogimoto A; Ohtsuka T; Shigematsu Y; Nakata S; Higaki J
    Cardiology; 2005; 104(1):16-21. PubMed ID: 15942178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta blockers in heart insufficiency].
    Noll G
    Praxis (Bern 1994); 1995 Mar; 84(11):313-8. PubMed ID: 7724947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
    Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
    J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry.
    DeVore AD; Mi X; Mentz RJ; Fonarow GC; Van Dyke MK; Maya JF; Hardy NC; Hammill BG; Hernandez AF
    Am Heart J; 2016 Mar; 173():172-8. PubMed ID: 26920611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of why and how we may use beta-blockers in congestive heart failure.
    Constant J
    Chest; 1998 Mar; 113(3):800-8. PubMed ID: 9515860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol.
    DasGupta P; Lahiri A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S62-7. PubMed ID: 1378153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.
    Woodley SL; Gilbert EM; Anderson JL; O'Connell JB; Deitchman D; Yanowitz FG; Mealey PC; Volkman K; Renlund DG; Menlove R
    Circulation; 1991 Dec; 84(6):2426-41. PubMed ID: 1683602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of atenolol as add-on therapy to fosinopril in heart failure.
    Pacher R; Hülsmann M; Berger R; Koller-Strametz J; Kos T; Frey B; Dukat A; Stanek B
    Wien Klin Wochenschr; 1997 Apr; 109(7):232-8. PubMed ID: 9141231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
    Bristow MR; O'Connell JB; Gilbert EM; French WJ; Leatherman G; Kantrowitz NE; Orie J; Smucker ML; Marshall G; Kelly P
    Circulation; 1994 Apr; 89(4):1632-42. PubMed ID: 7908610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.